Latest Research

Evaluating the Theoretical Content of Online Physical Activity Information for People with Multiple Sclerosis

Celina H. Shirazipour, MHK;Colin P.T. Baillie, MSc;Karla Galaviz, PhD;Jocelyn W. Jarvis, MSc;Amy E. Latimer-Cheung, PhD

Walgreens Connected Care

Janeen DuChane, PhD;Bobby Clark, PhD;Francis Staskon, PhD;Rick Miller, RPh, MBA;Kathleen Love, RN;Ian Duncan, FSA, FIA, FCIA, MAAA

Patient Preferences for Attributes of Multiple Sclerosis Disease-Modifying Therapies

Leslie S. Wilson, PhD;Aimee Loucks, PharmD;Gregory Gipson, PharmD;Lixian Zhong, PhD;Christine Bui, BS;Elizabeth Miller, MA;Mary Owen, RN;Daniel Pelletier, MD, FRCPC;Douglas Goodin, MD;Emmanuelle Waubant, MD, PhD;Charles E. McCulloch, PhD

A Randomized Placebo-Controlled Trial of Duloxetine for Central Pain in Multiple Sclerosis

Theodore R. Brown, MD, MPH;April Slee, MS

The 7-Item Generalized Anxiety Disorder Scale as a Tool for Measuring Generalized Anxiety in Multiple Sclerosis

Alexandra L. Terrill, PhD;Narineh Hartoonian, PhD;Meghan Beier, PhD;Rana Salem, MA;Kevin Alschuler, PhD

Does the Effect of a Physical Activity Behavioral Intervention Vary by Characteristics of People with Multiple Sclerosis?

Robert W. Motl, PhD;Deirdre Dlugonski, PhD;Lara A. Pilutti, PhD;Rachel E. Klaren, BS

Editorial - Volume 17, Issue 1 - January 2015

Francois Bethoux, MD

January 1st 2015

Effects of Functional Electrical Stimulation on Gait Function and Quality of Life for People with Multiple Sclerosis Taking Dalfampridine

Lori Mayer, MSN, MSCN, CCRP;Tina Warring, PT;Stephanie Agrella, ANP-BC, MSCN;Helen L. Rogers, PT, PhD;Edward J. Fox, MD, PhD

January 1st 2015

Lower Urinary Tract Symptom Prevalence and Management Among Patients with Multiple Sclerosis

Kristin M. Khalaf, PharmD, MS;Karin S. Coyne, PhD;Denise R. Globe, PhD;Edward P. Armstrong, PharmD;Daniel C. Malone, PhD;Jack Burks, MD

January 1st 2015

Disease-Related Determinants of Quality of Life 10 Years After Clinically Isolated Syndrome

R. Philip Kinkel, MD;Genevieve Laforet, MD, PhD;Xiaojun You, PhD

January 1st 2015

What Are the Support Needs of Men with Multiple Sclerosis, and Are They Being Met?

Dominic Upton, PhD;Charlotte Taylor, MSc

January 1st 2015

Development and Effectiveness of a Psychoeducational Wellness Program for People with Multiple Sclerosis

Kimberly Beckwith McGuire, PhD, ABPP, MSCS, FACHP;Jelena Stojanovic-Radic, PhD;Lauren Strober, PhD;Nancy D. Chiaravalloti, PhD;John DeLuca, PhD, ABPP

January 1st 2015

Informing the Children When a Parent Is Diagnosed as Having Multiple Sclerosis

Ylva Nilsagård, PhD;Katrin Boström, PhD

January 1st 2015

From the Editor

Francois Bethoux, MD

December 1st 2014

Correction - Volume 16, Issue 4 - December 2014

December 1st 2014

Poster Abstracts from the Fourth International Symposium on Gait and Balance in Multiple Sclerosis

December 1st 2014

Drawing on Related Knowledge to Advance Multiple Sclerosis Falls-Prevention Research

Amy E. Latimer-Cheung, PhD;Marcia Finlayson, PhD;Michelle Ploughman, PhD;Nandini Deshpande, PhD

December 1st 2014

Participation as an Outcome in Multiple Sclerosis Falls-Prevention Research

Marcia Finlayson, PhD, OT Reg (Ont), OTR;Elizabeth Peterson, PhD, OTR/L;Patricia N. Matsuda, PT, PhD, DPT

December 1st 2014

Whom to Target for Falls-Prevention Trials

Michelle Cameron, MD, PT, MCR;Jacob J. Sosnoff, PhD;Susan Coote, PhD, PT

December 1st 2014

Applying the RE-AIM Framework to Inform the Development of a Multiple Sclerosis Falls-Prevention Intervention

Marcia Finlayson, PhD, OT Reg (Ont), OTR;Davide Cattaneo, PT, PhD;Michelle Cameron, MD, PT, MCR;Susan Coote, PhD, PT;Patricia N. Matsuda, PT, PhD, DPT;Elizabeth Peterson, PhD, OTR/L;Jacob J. Sosnoff, PhD

December 1st 2014

Home or Away? Choosing a Setting for a Falls-Prevention Program for People with Multiple Sclerosis

Marcia Finlayson, PhD, OT Reg (Ont), OTR;Jennifer Freeman, PhD;Jacob J. Sosnoff, PhD;Hilary Gunn, MSc, PT;Davide Cattaneo, PT, PhD

December 1st 2014

Fall Incidence as the Primary Outcome in Multiple Sclerosis Falls-Prevention Trials

Susan Coote, PhD, PT;Jacob J. Sosnoff, PhD;Hilary Gunn, MSc, PT

December 1st 2014

International MS Falls Prevention Research Network

Jacob J. Sosnoff, PhD;Marcia Finlayson, PhD, OT Reg (Ont), OTR

December 1st 2014

Targeting Dynamic Balance in Falls-Prevention Interventions in Multiple Sclerosis

Davide Cattaneo, PT, PhD;Susan Coote, PhD, PT;Johanna Jonsdottir, PhD

December 1st 2014

Editorial - Volume 16, Issue 3 - October 2014

Francois Bethoux, MD

October 1st 2014

Informing Decisions to Improve the Continuum of Care in RRMS

October 1st 2014

Exclusive Use of Alternative Medicine as a Positive Choice

Lasse Skovgaard, MA, MA(Ed);Inge Kryger Pedersen, PhD;Marja Verhoef, PhD

October 1st 2014

Longitudinal Follow-up of a Cohort of Patients with Incidental Abnormal Magnetic Resonance Imaging Findings at Presentation and Their Risk of Developing Multiple Sclerosis

Mio Nakamura, BS;Mark Morris, BS;Mirela Cerghet, MD, PhD;Lonni Schultz, PhD;Stanton Elias, MD

October 1st 2014

A Pooled Analysis of Two Phase 3 Clinical Trials of Dalfampridine in Patients with Multiple Sclerosis

Andrew D. Goodman, MD;Theodore R. Brown, MD;Randall T. Schapiro, MD;Michael Klingler, MPH;Ron Cohen, MD;Andrew R. Blight, PhD

October 1st 2014

Effect of a 2-Week Trial of Functional Electrical Stimulation on Gait Function and Quality of Life in People with Multiple Sclerosis

Abbey Downing, CPO;David Van Ryn, CO;Anne Fecko, MS, OTR/L, CO;Christopher Aiken, CO;Sean McGowan, CO;Sarah Sawers, CO, LO;Thomas McInerny, CPO;Katie Moore, CP;Louis Passariello, CPO;Helen Rogers, PT, PhD

October 1st 2014

...

15 16 17 18 19 20 21 22 23

...